APO Research

APO RESEARCH · REPORT

Saliva Drug and Alcohol Testing

Selected research

Industry Research

Saliva Drug and Alcohol Testing Industry Research Report 2026

Market perspective

The global Saliva Drug and Alcohol Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Saliva Drug and Alcohol Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Saliva Drug and Alcohol Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Saliva Drug and Alcohol Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Saliva Drug and Alcohol Testing include Abbott, OraSure Technologies, Premier Biotech, Alcolizer, CareHealth America, AlphaBiolabs, AlcoDigital, VeriCheck and Azova, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Saliva Drug and Alcohol Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Saliva Drug and Alcohol Testing.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Saliva Drug and Alcohol Testing Market by Company

Abbott

OraSure Technologies

Premier Biotech

Alcolizer

CareHealth America

AlphaBiolabs

AlcoDigital

VeriCheck

Azova

Draeger

Securetec Detektions-Systeme

Quest Diagnostics

Oranoxis

Salimetrics

Neogen Corporation

UCP Biosciences

Lin-Zhi International

MEDACX

AccuBioTech

Wondfo Biotech

Assure Tech

Express Medicals

Crystal Health

KINNECT

AusHealth

Dorevitch Pathology

Labcorp

Eurofins

Concentra

Bellin Health

Randox

MediNat

Clinical Labs

MHE

Awanui Labs

David Barber Occupational Health

SYNLAB

Test Smartly Labs

Cansford Laboratories

Medigold Health

PAM Group

Drugwise

Safework Health

Humanomics

CannAmm

Micro-Distributing

Saliva Drug and Alcohol Testing Segment by Type

On-Site Screening Products

Lab Testing

Saliva Drug and Alcohol Testing Segment by Application

Criminal Justice Testing

Workplace Testing

Rehabilitation Therapy

Others

Saliva Drug and Alcohol Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Drug and Alcohol Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saliva Drug and Alcohol Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Drug and Alcohol Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Saliva Drug and Alcohol Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Saliva Drug and Alcohol Testing Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2021-2026) Table 7. Global Saliva Drug and Alcohol Testing Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2027-2032) Table 9. Global Saliva Drug and Alcohol Testing Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2021-2026) Table 11. Global Saliva Drug and Alcohol Testing Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2027-2032) Table 13. Global Saliva Drug and Alcohol Testing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Saliva Drug and Alcohol Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Saliva Drug and Alcohol Testing Market Share by Region (2021-2026) Table 16. Global Saliva Drug and Alcohol Testing Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Saliva Drug and Alcohol Testing Market Share by Region (2027-2032) Table 18. Saliva Drug and Alcohol Testing Industry Trends Table 19. Saliva Drug and Alcohol Testing Industry Drivers Table 20. Saliva Drug and Alcohol Testing Industry Opportunities and Challenges Table 21. Saliva Drug and Alcohol Testing Market Restraints Table 22. Global Top Saliva Drug and Alcohol Testing Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Saliva Drug and Alcohol Testing Revenue Market Share by Players (2021-2026) Table 24. Global Saliva Drug and Alcohol Testing Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Saliva Drug and Alcohol Testing, Headquarters and Area Served Table 26. Global Saliva Drug and Alcohol Testing Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Saliva Drug and Alcohol Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Saliva Drug and Alcohol Testing Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Saliva Drug and Alcohol Testing Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Saliva Drug and Alcohol Testing Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Saliva Drug and Alcohol Testing Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2027-2032) & (US$ Million) Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 48. Abbott Saliva Drug and Alcohol Testing Product Portfolio Table 49. Abbott Recent Developments Table 50. OraSure Technologies Company Information Table 51. OraSure Technologies Business Overview Table 52. OraSure Technologies Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 53. OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio Table 54. OraSure Technologies Recent Developments Table 55. Premier Biotech Company Information Table 56. Premier Biotech Business Overview Table 57. Premier Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 58. Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 59. Premier Biotech Recent Developments Table 60. Alcolizer Company Information Table 61. Alcolizer Business Overview Table 62. Alcolizer Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 63. Alcolizer Saliva Drug and Alcohol Testing Product Portfolio Table 64. Alcolizer Recent Developments Table 65. CareHealth America Company Information Table 66. CareHealth America Business Overview Table 67. CareHealth America Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 68. CareHealth America Saliva Drug and Alcohol Testing Product Portfolio Table 69. CareHealth America Recent Developments Table 70. AlphaBiolabs Company Information Table 71. AlphaBiolabs Business Overview Table 72. AlphaBiolabs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 73. AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio Table 74. AlphaBiolabs Recent Developments Table 75. AlcoDigital Company Information Table 76. AlcoDigital Business Overview Table 77. AlcoDigital Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 78. AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio Table 79. AlcoDigital Recent Developments Table 80. VeriCheck Company Information Table 81. VeriCheck Business Overview Table 82. VeriCheck Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 83. VeriCheck Saliva Drug and Alcohol Testing Product Portfolio Table 84. VeriCheck Recent Developments Table 85. Azova Company Information Table 86. Azova Business Overview Table 87. Azova Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 88. Azova Saliva Drug and Alcohol Testing Product Portfolio Table 89. Azova Recent Developments Table 90. Draeger Company Information Table 91. Draeger Business Overview Table 92. Draeger Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 93. Draeger Saliva Drug and Alcohol Testing Product Portfolio Table 94. Draeger Recent Developments Table 95. Securetec Detektions-Systeme Company Information Table 96. Securetec Detektions-Systeme Business Overview Table 97. Securetec Detektions-Systeme Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 98. Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio Table 99. Securetec Detektions-Systeme Recent Developments Table 100. Quest Diagnostics Company Information Table 101. Quest Diagnostics Business Overview Table 102. Quest Diagnostics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 103. Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio Table 104. Quest Diagnostics Recent Developments Table 105. Oranoxis Company Information Table 106. Oranoxis Business Overview Table 107. Oranoxis Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 108. Oranoxis Saliva Drug and Alcohol Testing Product Portfolio Table 109. Oranoxis Recent Developments Table 110. Salimetrics Company Information Table 111. Salimetrics Business Overview Table 112. Salimetrics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 113. Salimetrics Saliva Drug and Alcohol Testing Product Portfolio Table 114. Salimetrics Recent Developments Table 115. Neogen Corporation Company Information Table 116. Neogen Corporation Business Overview Table 117. Neogen Corporation Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 118. Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio Table 119. Neogen Corporation Recent Developments Table 120. UCP Biosciences Company Information Table 121. UCP Biosciences Business Overview Table 122. UCP Biosciences Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 123. UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio Table 124. UCP Biosciences Recent Developments Table 125. Lin-Zhi International Company Information Table 126. Lin-Zhi International Business Overview Table 127. Lin-Zhi International Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 128. Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio Table 129. Lin-Zhi International Recent Developments Table 130. MEDACX Company Information Table 131. MEDACX Business Overview Table 132. MEDACX Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 133. MEDACX Saliva Drug and Alcohol Testing Product Portfolio Table 134. MEDACX Recent Developments Table 135. AccuBioTech Company Information Table 136. AccuBioTech Business Overview Table 137. AccuBioTech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 138. AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio Table 139. AccuBioTech Recent Developments Table 140. Wondfo Biotech Company Information Table 141. Wondfo Biotech Business Overview Table 142. Wondfo Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 143. Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 144. Wondfo Biotech Recent Developments Table 145. Assure Tech Company Information Table 146. Assure Tech Business Overview Table 147. Assure Tech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 148. Assure Tech Saliva Drug and Alcohol Testing Product Portfolio Table 149. Assure Tech Recent Developments Table 150. Express Medicals Company Information Table 151. Express Medicals Business Overview Table 152. Express Medicals Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 153. Express Medicals Saliva Drug and Alcohol Testing Product Portfolio Table 154. Express Medicals Recent Developments Table 155. Crystal Health Company Information Table 156. Crystal Health Business Overview Table 157. Crystal Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 158. Crystal Health Saliva Drug and Alcohol Testing Product Portfolio Table 159. Crystal Health Recent Developments Table 160. KINNECT Company Information Table 161. KINNECT Business Overview Table 162. KINNECT Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 163. KINNECT Saliva Drug and Alcohol Testing Product Portfolio Table 164. KINNECT Recent Developments Table 165. AusHealth Company Information Table 166. AusHealth Business Overview Table 167. AusHealth Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 168. AusHealth Saliva Drug and Alcohol Testing Product Portfolio Table 169. AusHealth Recent Developments Table 170. Dorevitch Pathology Company Information Table 171. Dorevitch Pathology Business Overview Table 172. Dorevitch Pathology Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 173. Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio Table 174. Dorevitch Pathology Recent Developments Table 175. Labcorp Company Information Table 176. Labcorp Business Overview Table 177. Labcorp Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 178. Labcorp Saliva Drug and Alcohol Testing Product Portfolio Table 179. Labcorp Recent Developments Table 180. Eurofins Company Information Table 181. Eurofins Business Overview Table 182. Eurofins Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 183. Eurofins Saliva Drug and Alcohol Testing Product Portfolio Table 184. Eurofins Recent Developments Table 185. Concentra Company Information Table 186. Concentra Business Overview Table 187. Concentra Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 188. Concentra Saliva Drug and Alcohol Testing Product Portfolio Table 189. Concentra Recent Developments Table 190. Bellin Health Company Information Table 191. Bellin Health Business Overview Table 192. Bellin Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 193. Bellin Health Saliva Drug and Alcohol Testing Product Portfolio Table 194. Bellin Health Recent Developments Table 195. Randox Company Information Table 196. Randox Business Overview Table 197. Randox Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 198. Randox Saliva Drug and Alcohol Testing Product Portfolio Table 199. Randox Recent Developments Table 200. MediNat Company Information Table 201. MediNat Business Overview Table 202. MediNat Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 203. MediNat Saliva Drug and Alcohol Testing Product Portfolio Table 204. MediNat Recent Developments Table 205. Clinical Labs Company Information Table 206. Clinical Labs Business Overview Table 207. Clinical Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 208. Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio Table 209. Clinical Labs Recent Developments Table 210. MHE Company Information Table 211. MHE Business Overview Table 212. MHE Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 213. MHE Saliva Drug and Alcohol Testing Product Portfolio Table 214. MHE Recent Developments Table 215. Awanui Labs Company Information Table 216. Awanui Labs Business Overview Table 217. Awanui Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 218. Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio Table 219. Awanui Labs Recent Developments Table 220. David Barber Occupational Health Company Information Table 221. David Barber Occupational Health Business Overview Table 222. David Barber Occupational Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 223. David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio Table 224. David Barber Occupational Health Recent Developments Table 225. SYNLAB Company Information Table 226. SYNLAB Business Overview Table 227. SYNLAB Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 228. SYNLAB Saliva Drug and Alcohol Testing Product Portfolio Table 229. SYNLAB Recent Developments Table 230. Test Smartly Labs Company Information Table 231. Test Smartly Labs Business Overview Table 232. Test Smartly Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 233. Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio Table 234. Test Smartly Labs Recent Developments Table 235. Cansford Laboratories Company Information Table 236. Cansford Laboratories Business Overview Table 237. Cansford Laboratories Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 238. Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio Table 239. Cansford Laboratories Recent Developments Table 240. Medigold Health Company Information Table 241. Medigold Health Business Overview Table 242. Medigold Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 243. Medigold Health Saliva Drug and Alcohol Testing Product Portfolio Table 244. Medigold Health Recent Developments Table 245. PAM Group Company Information Table 246. PAM Group Business Overview Table 247. PAM Group Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 248. PAM Group Saliva Drug and Alcohol Testing Product Portfolio Table 249. PAM Group Recent Developments Table 250. Drugwise Company Information Table 251. Drugwise Business Overview Table 252. Drugwise Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 253. Drugwise Saliva Drug and Alcohol Testing Product Portfolio Table 254. Drugwise Recent Developments Table 255. Safework Health Company Information Table 256. Safework Health Business Overview Table 257. Safework Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 258. Safework Health Saliva Drug and Alcohol Testing Product Portfolio Table 259. Safework Health Recent Developments Table 260. Humanomics Company Information Table 261. Humanomics Business Overview Table 262. Humanomics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 263. Humanomics Saliva Drug and Alcohol Testing Product Portfolio Table 264. Humanomics Recent Developments Table 265. CannAmm Company Information Table 266. CannAmm Business Overview Table 267. CannAmm Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 268. CannAmm Saliva Drug and Alcohol Testing Product Portfolio Table 269. CannAmm Recent Developments Table 270. Micro-Distributing Company Information Table 271. Micro-Distributing Business Overview Table 272. Micro-Distributing Revenue in Saliva Drug and Alcohol Testing Business (2021-2026) & (US$ Million) Table 273. Micro-Distributing Saliva Drug and Alcohol Testing Product Portfolio Table 274. Micro-Distributing Recent Developments Table 275. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Saliva Drug and Alcohol Testing Product Image Figure 5. Global Saliva Drug and Alcohol Testing Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Saliva Drug and Alcohol Testing Market Share by Type: 2025 VS 2032 Figure 7. On-Site Screening Products Product Figure 8. Lab Testing Product Figure 9. Global Saliva Drug and Alcohol Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Saliva Drug and Alcohol Testing Market Share by Application: 2025 VS 2032 Figure 11. Criminal Justice Testing Product Figure 12. Workplace Testing Product Figure 13. Rehabilitation Therapy Product Figure 14. Others Product Figure 15. Global Saliva Drug and Alcohol Testing Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Saliva Drug and Alcohol Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Saliva Drug and Alcohol Testing Market Share by Region: 2025 VS 2032 Figure 18. Global Saliva Drug and Alcohol Testing Market Share by Players in 2025 Figure 19. Global Saliva Drug and Alcohol Testing Manufacturers Established Date Figure 20. Global Top 5 and 10 Saliva Drug and Alcohol Testing Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 24. United States Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 27. Europe Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 29. Germany Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 39. China Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 44. Australia Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Saliva Drug and Alcohol Testing Market Share by Country (2021-2032) Figure 49. Brazil Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Saliva Drug and Alcohol Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Abbott Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 55. OraSure Technologies Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 56. Premier Biotech Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 57. Alcolizer Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 58. CareHealth America Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 59. AlphaBiolabs Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 60. AlcoDigital Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 61. VeriCheck Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 62. Azova Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 63. Draeger Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 64. Securetec Detektions-Systeme Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 65. Quest Diagnostics Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 66. Oranoxis Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 67. Salimetrics Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 68. Neogen Corporation Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 69. UCP Biosciences Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 70. Lin-Zhi International Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 71. MEDACX Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 72. AccuBioTech Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 73. Wondfo Biotech Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 74. Assure Tech Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 75. Express Medicals Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 76. Crystal Health Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 77. KINNECT Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 78. AusHealth Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 79. Dorevitch Pathology Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 80. Labcorp Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 81. Eurofins Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 82. Concentra Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 83. Bellin Health Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 84. Randox Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 85. MediNat Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 86. Clinical Labs Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 87. MHE Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 88. Awanui Labs Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 89. David Barber Occupational Health Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 90. SYNLAB Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 91. Test Smartly Labs Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 92. Cansford Laboratories Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 93. Medigold Health Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 94. PAM Group Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 95. Drugwise Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 96. Safework Health Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 97. Humanomics Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 98. CannAmm Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026) Figure 99. Micro-Distributing Revenue Growth Rate in Saliva Drug and Alcohol Testing Business (2021-2026)

Scope & coverage.

Types
  • On-Site Screening Products
  • Lab Testing
Applications
  • Criminal Justice Testing
  • Workplace Testing
  • Rehabilitation Therapy
  • Others
Companies covered
  • Abbott
  • OraSure Technologies
  • Premier Biotech
  • Alcolizer
  • CareHealth America
  • AlphaBiolabs
  • AlcoDigital
  • VeriCheck
  • Azova
  • Draeger
  • Securetec Detektions-Systeme
  • Quest Diagnostics
  • Oranoxis
  • Salimetrics
  • Neogen Corporation
  • UCP Biosciences
  • Lin-Zhi International
  • MEDACX
  • AccuBioTech
  • Wondfo Biotech
  • Assure Tech
  • Express Medicals
  • Crystal Health
  • KINNECT
  • AusHealth
  • Dorevitch Pathology
  • Labcorp
  • Eurofins
  • Concentra
  • Bellin Health
  • Randox
  • MediNat
  • Clinical Labs
  • MHE
  • Awanui Labs
  • David Barber Occupational Health
  • SYNLAB
  • Test Smartly Labs
  • Cansford Laboratories
  • Medigold Health
  • PAM Group
  • Drugwise
  • Safework Health
  • Humanomics
  • CannAmm
  • Micro-Distributing

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Saliva Drug and Alcohol Testing by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 On-Site Screening Products
  5. 2.2.3 Lab Testing
  6. 2.3 Saliva Drug and Alcohol Testing by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Criminal Justice Testing
  9. 2.3.3 Workplace Testing
  10. 2.3.4 Rehabilitation Therapy
  11. 2.3.5 Others
  12. 2.4 Assumptions and Limitations
3 Saliva Drug and Alcohol Testing Breakdown Data by Type
  1. 3.1 Global Saliva Drug and Alcohol Testing Historic Market Size by Type (2021-2026)
  2. 3.2 Global Saliva Drug and Alcohol Testing Forecasted Market Size by Type (2027-2032)
4 Saliva Drug and Alcohol Testing Breakdown Data by Application
  1. 4.1 Global Saliva Drug and Alcohol Testing Historic Market Size by Application (2021-2026)
  2. 4.2 Global Saliva Drug and Alcohol Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Saliva Drug and Alcohol Testing Market Perspective (2021-2032)
  2. 5.2 Global Saliva Drug and Alcohol Testing Growth Trends by Region
  3. 5.2.1 Global Saliva Drug and Alcohol Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Saliva Drug and Alcohol Testing Historic Market Size by Region (2021-2026)
  5. 5.2.3 Saliva Drug and Alcohol Testing Forecasted Market Size by Region (2027-2032)
  6. 5.3 Saliva Drug and Alcohol Testing Market Dynamics
  7. 5.3.1 Saliva Drug and Alcohol Testing Industry Trends
  8. 5.3.2 Saliva Drug and Alcohol Testing Market Drivers
  9. 5.3.3 Saliva Drug and Alcohol Testing Market Challenges
  10. 5.3.4 Saliva Drug and Alcohol Testing Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Saliva Drug and Alcohol Testing Players by Revenue
  2. 6.1.1 Global Top Saliva Drug and Alcohol Testing Players by Revenue (2021-2026)
  3. 6.1.2 Global Saliva Drug and Alcohol Testing Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Saliva Drug and Alcohol Testing Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Saliva Drug and Alcohol Testing Head Office and Area Served
  6. 6.4 Global Saliva Drug and Alcohol Testing Players, Product Type & Application
  7. 6.5 Global Saliva Drug and Alcohol Testing Manufacturers Established Date
  8. 6.6 Global Saliva Drug and Alcohol Testing Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Saliva Drug and Alcohol Testing Market Size (2021-2032)
  2. 7.2 North America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
  4. 7.4 North America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Saliva Drug and Alcohol Testing Market Size (2021-2032)
  2. 8.2 Europe Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
  4. 8.4 Europe Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Saliva Drug and Alcohol Testing Market Size (2021-2032)
  2. 9.2 Asia-Pacific Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Saliva Drug and Alcohol Testing Market Size (2021-2032)
  2. 10.2 South America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
  4. 10.4 South America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Saliva Drug and Alcohol Testing Market Size (2021-2032)
  2. 11.2 Middle East & Africa Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Abbott
  2. 12.1.1 Abbott Company Information
  3. 12.1.2 Abbott Business Overview
  4. 12.1.3 Abbott Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  5. 12.1.4 Abbott Saliva Drug and Alcohol Testing Product Portfolio
  6. 12.1.5 Abbott Recent Developments
  7. 12.2 OraSure Technologies
  8. 12.2.1 OraSure Technologies Company Information
  9. 12.2.2 OraSure Technologies Business Overview
  10. 12.2.3 OraSure Technologies Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  11. 12.2.4 OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio
  12. 12.2.5 OraSure Technologies Recent Developments
  13. 12.3 Premier Biotech
  14. 12.3.1 Premier Biotech Company Information
  15. 12.3.2 Premier Biotech Business Overview
  16. 12.3.3 Premier Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  17. 12.3.4 Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio
  18. 12.3.5 Premier Biotech Recent Developments
  19. 12.4 Alcolizer
  20. 12.4.1 Alcolizer Company Information
  21. 12.4.2 Alcolizer Business Overview
  22. 12.4.3 Alcolizer Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  23. 12.4.4 Alcolizer Saliva Drug and Alcohol Testing Product Portfolio
  24. 12.4.5 Alcolizer Recent Developments
  25. 12.5 CareHealth America
  26. 12.5.1 CareHealth America Company Information
  27. 12.5.2 CareHealth America Business Overview
  28. 12.5.3 CareHealth America Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  29. 12.5.4 CareHealth America Saliva Drug and Alcohol Testing Product Portfolio
  30. 12.5.5 CareHealth America Recent Developments
  31. 12.6 AlphaBiolabs
  32. 12.6.1 AlphaBiolabs Company Information
  33. 12.6.2 AlphaBiolabs Business Overview
  34. 12.6.3 AlphaBiolabs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  35. 12.6.4 AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio
  36. 12.6.5 AlphaBiolabs Recent Developments
  37. 12.7 AlcoDigital
  38. 12.7.1 AlcoDigital Company Information
  39. 12.7.2 AlcoDigital Business Overview
  40. 12.7.3 AlcoDigital Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  41. 12.7.4 AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio
  42. 12.7.5 AlcoDigital Recent Developments
  43. 12.8 VeriCheck
  44. 12.8.1 VeriCheck Company Information
  45. 12.8.2 VeriCheck Business Overview
  46. 12.8.3 VeriCheck Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  47. 12.8.4 VeriCheck Saliva Drug and Alcohol Testing Product Portfolio
  48. 12.8.5 VeriCheck Recent Developments
  49. 12.9 Azova
  50. 12.9.1 Azova Company Information
  51. 12.9.2 Azova Business Overview
  52. 12.9.3 Azova Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  53. 12.9.4 Azova Saliva Drug and Alcohol Testing Product Portfolio
  54. 12.9.5 Azova Recent Developments
  55. 12.10 Draeger
  56. 12.10.1 Draeger Company Information
  57. 12.10.2 Draeger Business Overview
  58. 12.10.3 Draeger Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  59. 12.10.4 Draeger Saliva Drug and Alcohol Testing Product Portfolio
  60. 12.10.5 Draeger Recent Developments
  61. 12.11 Securetec Detektions-Systeme
  62. 12.11.1 Securetec Detektions-Systeme Company Information
  63. 12.11.2 Securetec Detektions-Systeme Business Overview
  64. 12.11.3 Securetec Detektions-Systeme Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  65. 12.11.4 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio
  66. 12.11.5 Securetec Detektions-Systeme Recent Developments
  67. 12.12 Quest Diagnostics
  68. 12.12.1 Quest Diagnostics Company Information
  69. 12.12.2 Quest Diagnostics Business Overview
  70. 12.12.3 Quest Diagnostics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  71. 12.12.4 Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio
  72. 12.12.5 Quest Diagnostics Recent Developments
  73. 12.13 Oranoxis
  74. 12.13.1 Oranoxis Company Information
  75. 12.13.2 Oranoxis Business Overview
  76. 12.13.3 Oranoxis Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  77. 12.13.4 Oranoxis Saliva Drug and Alcohol Testing Product Portfolio
  78. 12.13.5 Oranoxis Recent Developments
  79. 12.14 Salimetrics
  80. 12.14.1 Salimetrics Company Information
  81. 12.14.2 Salimetrics Business Overview
  82. 12.14.3 Salimetrics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  83. 12.14.4 Salimetrics Saliva Drug and Alcohol Testing Product Portfolio
  84. 12.14.5 Salimetrics Recent Developments
  85. 12.15 Neogen Corporation
  86. 12.15.1 Neogen Corporation Company Information
  87. 12.15.2 Neogen Corporation Business Overview
  88. 12.15.3 Neogen Corporation Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  89. 12.15.4 Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio
  90. 12.15.5 Neogen Corporation Recent Developments
  91. 12.16 UCP Biosciences
  92. 12.16.1 UCP Biosciences Company Information
  93. 12.16.2 UCP Biosciences Business Overview
  94. 12.16.3 UCP Biosciences Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  95. 12.16.4 UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio
  96. 12.16.5 UCP Biosciences Recent Developments
  97. 12.17 Lin-Zhi International
  98. 12.17.1 Lin-Zhi International Company Information
  99. 12.17.2 Lin-Zhi International Business Overview
  100. 12.17.3 Lin-Zhi International Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  101. 12.17.4 Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio
  102. 12.17.5 Lin-Zhi International Recent Developments
  103. 12.18 MEDACX
  104. 12.18.1 MEDACX Company Information
  105. 12.18.2 MEDACX Business Overview
  106. 12.18.3 MEDACX Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  107. 12.18.4 MEDACX Saliva Drug and Alcohol Testing Product Portfolio
  108. 12.18.5 MEDACX Recent Developments
  109. 12.19 AccuBioTech
  110. 12.19.1 AccuBioTech Company Information
  111. 12.19.2 AccuBioTech Business Overview
  112. 12.19.3 AccuBioTech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  113. 12.19.4 AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio
  114. 12.19.5 AccuBioTech Recent Developments
  115. 12.20 Wondfo Biotech
  116. 12.20.1 Wondfo Biotech Company Information
  117. 12.20.2 Wondfo Biotech Business Overview
  118. 12.20.3 Wondfo Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  119. 12.20.4 Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio
  120. 12.20.5 Wondfo Biotech Recent Developments
  121. 12.21 Assure Tech
  122. 12.21.1 Assure Tech Company Information
  123. 12.21.2 Assure Tech Business Overview
  124. 12.21.3 Assure Tech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  125. 12.21.4 Assure Tech Saliva Drug and Alcohol Testing Product Portfolio
  126. 12.21.5 Assure Tech Recent Developments
  127. 12.22 Express Medicals
  128. 12.22.1 Express Medicals Company Information
  129. 12.22.2 Express Medicals Business Overview
  130. 12.22.3 Express Medicals Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  131. 12.22.4 Express Medicals Saliva Drug and Alcohol Testing Product Portfolio
  132. 12.22.5 Express Medicals Recent Developments
  133. 12.23 Crystal Health
  134. 12.23.1 Crystal Health Company Information
  135. 12.23.2 Crystal Health Business Overview
  136. 12.23.3 Crystal Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  137. 12.23.4 Crystal Health Saliva Drug and Alcohol Testing Product Portfolio
  138. 12.23.5 Crystal Health Recent Developments
  139. 12.24 KINNECT
  140. 12.24.1 KINNECT Company Information
  141. 12.24.2 KINNECT Business Overview
  142. 12.24.3 KINNECT Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  143. 12.24.4 KINNECT Saliva Drug and Alcohol Testing Product Portfolio
  144. 12.24.5 KINNECT Recent Developments
  145. 12.25 AusHealth
  146. 12.25.1 AusHealth Company Information
  147. 12.25.2 AusHealth Business Overview
  148. 12.25.3 AusHealth Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  149. 12.25.4 AusHealth Saliva Drug and Alcohol Testing Product Portfolio
  150. 12.25.5 AusHealth Recent Developments
  151. 12.26 Dorevitch Pathology
  152. 12.26.1 Dorevitch Pathology Company Information
  153. 12.26.2 Dorevitch Pathology Business Overview
  154. 12.26.3 Dorevitch Pathology Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  155. 12.26.4 Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio
  156. 12.26.5 Dorevitch Pathology Recent Developments
  157. 12.27 Labcorp
  158. 12.27.1 Labcorp Company Information
  159. 12.27.2 Labcorp Business Overview
  160. 12.27.3 Labcorp Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  161. 12.27.4 Labcorp Saliva Drug and Alcohol Testing Product Portfolio
  162. 12.27.5 Labcorp Recent Developments
  163. 12.28 Eurofins
  164. 12.28.1 Eurofins Company Information
  165. 12.28.2 Eurofins Business Overview
  166. 12.28.3 Eurofins Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  167. 12.28.4 Eurofins Saliva Drug and Alcohol Testing Product Portfolio
  168. 12.28.5 Eurofins Recent Developments
  169. 12.29 Concentra
  170. 12.29.1 Concentra Company Information
  171. 12.29.2 Concentra Business Overview
  172. 12.29.3 Concentra Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  173. 12.29.4 Concentra Saliva Drug and Alcohol Testing Product Portfolio
  174. 12.29.5 Concentra Recent Developments
  175. 12.30 Bellin Health
  176. 12.30.1 Bellin Health Company Information
  177. 12.30.2 Bellin Health Business Overview
  178. 12.30.3 Bellin Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  179. 12.30.4 Bellin Health Saliva Drug and Alcohol Testing Product Portfolio
  180. 12.30.5 Bellin Health Recent Developments
  181. 12.31 Randox
  182. 12.31.1 Randox Company Information
  183. 12.31.2 Randox Business Overview
  184. 12.31.3 Randox Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  185. 12.31.4 Randox Saliva Drug and Alcohol Testing Product Portfolio
  186. 12.31.5 Randox Recent Developments
  187. 12.32 MediNat
  188. 12.32.1 MediNat Company Information
  189. 12.32.2 MediNat Business Overview
  190. 12.32.3 MediNat Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  191. 12.32.4 MediNat Saliva Drug and Alcohol Testing Product Portfolio
  192. 12.32.5 MediNat Recent Developments
  193. 12.33 Clinical Labs
  194. 12.33.1 Clinical Labs Company Information
  195. 12.33.2 Clinical Labs Business Overview
  196. 12.33.3 Clinical Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  197. 12.33.4 Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio
  198. 12.33.5 Clinical Labs Recent Developments
  199. 12.34 MHE
  200. 12.34.1 MHE Company Information
  201. 12.34.2 MHE Business Overview
  202. 12.34.3 MHE Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  203. 12.34.4 MHE Saliva Drug and Alcohol Testing Product Portfolio
  204. 12.34.5 MHE Recent Developments
  205. 12.35 Awanui Labs
  206. 12.35.1 Awanui Labs Company Information
  207. 12.35.2 Awanui Labs Business Overview
  208. 12.35.3 Awanui Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  209. 12.35.4 Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio
  210. 12.35.5 Awanui Labs Recent Developments
  211. 12.36 David Barber Occupational Health
  212. 12.36.1 David Barber Occupational Health Company Information
  213. 12.36.2 David Barber Occupational Health Business Overview
  214. 12.36.3 David Barber Occupational Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  215. 12.36.4 David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio
  216. 12.36.5 David Barber Occupational Health Recent Developments
  217. 12.37 SYNLAB
  218. 12.37.1 SYNLAB Company Information
  219. 12.37.2 SYNLAB Business Overview
  220. 12.37.3 SYNLAB Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  221. 12.37.4 SYNLAB Saliva Drug and Alcohol Testing Product Portfolio
  222. 12.37.5 SYNLAB Recent Developments
  223. 12.38 Test Smartly Labs
  224. 12.38.1 Test Smartly Labs Company Information
  225. 12.38.2 Test Smartly Labs Business Overview
  226. 12.38.3 Test Smartly Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  227. 12.38.4 Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio
  228. 12.38.5 Test Smartly Labs Recent Developments
  229. 12.39 Cansford Laboratories
  230. 12.39.1 Cansford Laboratories Company Information
  231. 12.39.2 Cansford Laboratories Business Overview
  232. 12.39.3 Cansford Laboratories Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  233. 12.39.4 Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio
  234. 12.39.5 Cansford Laboratories Recent Developments
  235. 12.40 Medigold Health
  236. 12.40.1 Medigold Health Company Information
  237. 12.40.2 Medigold Health Business Overview
  238. 12.40.3 Medigold Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  239. 12.40.4 Medigold Health Saliva Drug and Alcohol Testing Product Portfolio
  240. 12.40.5 Medigold Health Recent Developments
  241. 12.41 PAM Group
  242. 12.41.1 PAM Group Company Information
  243. 12.41.2 PAM Group Business Overview
  244. 12.41.3 PAM Group Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  245. 12.41.4 PAM Group Saliva Drug and Alcohol Testing Product Portfolio
  246. 12.41.5 PAM Group Recent Developments
  247. 12.42 Drugwise
  248. 12.42.1 Drugwise Company Information
  249. 12.42.2 Drugwise Business Overview
  250. 12.42.3 Drugwise Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  251. 12.42.4 Drugwise Saliva Drug and Alcohol Testing Product Portfolio
  252. 12.42.5 Drugwise Recent Developments
  253. 12.43 Safework Health
  254. 12.43.1 Safework Health Company Information
  255. 12.43.2 Safework Health Business Overview
  256. 12.43.3 Safework Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  257. 12.43.4 Safework Health Saliva Drug and Alcohol Testing Product Portfolio
  258. 12.43.5 Safework Health Recent Developments
  259. 12.44 Humanomics
  260. 12.44.1 Humanomics Company Information
  261. 12.44.2 Humanomics Business Overview
  262. 12.44.3 Humanomics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  263. 12.44.4 Humanomics Saliva Drug and Alcohol Testing Product Portfolio
  264. 12.44.5 Humanomics Recent Developments
  265. 12.45 CannAmm
  266. 12.45.1 CannAmm Company Information
  267. 12.45.2 CannAmm Business Overview
  268. 12.45.3 CannAmm Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  269. 12.45.4 CannAmm Saliva Drug and Alcohol Testing Product Portfolio
  270. 12.45.5 CannAmm Recent Developments
  271. 12.46 Micro-Distributing
  272. 12.46.1 Micro-Distributing Company Information
  273. 12.46.2 Micro-Distributing Business Overview
  274. 12.46.3 Micro-Distributing Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
  275. 12.46.4 Micro-Distributing Saliva Drug and Alcohol Testing Product Portfolio
  276. 12.46.5 Micro-Distributing Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research